Holdings
Sector Gamma As
As of Sep 30, 2026, Sector Gamma As reported 37 positions worth US$430M. Largest: Bristol-Myers Squibb Company, Pfizer, Inc. and Merck & Company, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Bristol-Myers Squibb Company | 613K | US$38.2M | −113K | Sep 30, 2026 |
| Pfizer, Inc. | 1.27M | US$36.1M | +263K | Sep 30, 2026 |
| Merck & Company, Inc. | 193K | US$28.1M | −23,964 | Sep 30, 2026 |
| Incyte Corporation | 155K | US$18.8M | −15,653 | Sep 30, 2026 |
| BioMarin Pharmaceutical Inc. | 293K | US$17.6M | −1,625 | Sep 30, 2026 |
| CVS Health Corporation | 197K | US$16.8M | +41,237 | Sep 30, 2026 |
| GE HealthCare Technologies Inc. | 257K | US$16.8M | +49,043 | Sep 30, 2026 |
| Elevance Health, Inc. | 40,229 | US$15.6M | −4,270 | Sep 30, 2026 |
| Biogen Inc. | 66,646 | US$15.1M | +12,483 | Sep 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 330K | US$14.7M | +141K | Sep 30, 2026 |